BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32269301)

  • 1. Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities.
    Eldesouky HE; Salama EA; Hazbun TR; Mayhoub AS; Seleem MN
    Sci Rep; 2020 Apr; 10(1):6089. PubMed ID: 32269301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent Synergistic Interactions between Lopinavir and Azole Antifungal Drugs against Emerging Multidrug-Resistant Candida auris.
    Eldesouky HE; Salama EA; Lanman NA; Hazbun TR; Seleem MN
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris.
    Eldesouky HE; Li X; Abutaleb NS; Mohammad H; Seleem MN
    Int J Antimicrob Agents; 2018 Dec; 52(6):754-761. PubMed ID: 30145250
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
    Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of
    Eldesouky HE; Lanman NA; Hazbun TR; Seleem MN
    Virulence; 2020 Dec; 11(1):1466-1481. PubMed ID: 33100149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.
    Fraczek MG; Bromley M; Buied A; Moore CB; Rajendran R; Rautemaa R; Ramage G; Denning DW; Bowyer P
    J Antimicrob Chemother; 2013 Jul; 68(7):1486-96. PubMed ID: 23580559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains.
    Scalas D; Mandras N; Roana J; Tardugno R; Cuffini AM; Ghisetti V; Benvenuti S; Tullio V
    BMC Complement Altern Med; 2018 May; 18(1):143. PubMed ID: 29724221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species.
    Eldesouky HE; Salama EA; Li X; Hazbun TR; Mayhoub AS; Seleem MN
    Sci Rep; 2020 May; 10(1):7525. PubMed ID: 32372011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
    Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
    Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Colley T; Alanio A; Kelly SL; Sehra G; Kizawa Y; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Anderson-Dring L; Nakaoki T; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; Cooke M; Bretagne S; King-Underwood J; Murray J; Ito K; Strong P; Rapeport G
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic
    Revie NM; Robbins N; Whitesell L; Frost JR; Appavoo SD; Yudin AK; Cowen LE
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole drug import into the pathogenic fungus Aspergillus fumigatus.
    Esquivel BD; Smith AR; Zavrel M; White TC
    Antimicrob Agents Chemother; 2015; 59(6):3390-8. PubMed ID: 25824209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
    Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saquinavir potentiates itraconazole's antifungal activity against multidrug-resistant Candida auris in vitro andin vivo.
    Elgammal Y; Salama EA; Seleem MN
    Med Mycol; 2023 Sep; 61(9):. PubMed ID: 37558393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Zn2-Cys6 Transcription Factor AtrR Plays a Key Role in an Azole Resistance Mechanism of Aspergillus fumigatus by Co-regulating cyp51A and cdr1B Expressions.
    Hagiwara D; Miura D; Shimizu K; Paul S; Ohba A; Gonoi T; Watanabe A; Kamei K; Shintani T; Moye-Rowley WS; Kawamoto S; Gomi K
    PLoS Pathog; 2017 Jan; 13(1):e1006096. PubMed ID: 28052140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis.
    Salama EA; Eldesouky HE; Elgammal Y; Abutaleb NS; Seleem MN
    Int J Antimicrob Agents; 2023 Sep; 62(3):106906. PubMed ID: 37392947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.